生殖支原体16S rRNA突变与四环素耐药关联研究
该研究通过体外诱导和临床样本测序,探究沙眼衣原体和生殖支原体对四环素的耐药性发展。体外传代30代未筛选出耐药株,16S rRNA基因无突变;但6份生殖支原体阳性临床样本携带可能与四环素耐药相关的16S rRNA突变,且患者无已知既往四环素治疗史。
要点
- 体外连续传代30代未诱导出沙眼衣原体和生殖支原体对四环素/多西环素的耐药。
- 生殖支原体临床样本中检出6例16S rRNA突变,可能与四环素耐药相关。
- 沙眼衣原体临床样本中未检测到16S rRNA基因突变。
核心结论
- 四环素体外未筛选出沙眼衣原体或生殖支原体耐药突变株。
- 部分生殖支原体临床样本存在可能与四环素耐药相关的16S rRNA突变,且患者无已知既往四环素治疗史。
研究设计与样本
- 体外研究对沙眼衣原体和生殖支原体参考株进行四环素或多西环素亚抑菌浓度连续传代,并测序16S rRNA基因。
- 同时测序2013至2019年法国收集的43份沙眼衣原体阳性和106份生殖支原体阳性临床标本的16S rRNA基因。
主要发现
- 体外传代30代后,沙眼衣原体和生殖支原体的四环素及多西环素MIC值不变,16S rRNA基因未发现突变。
- 43份沙眼衣原体阳性标本中未检测到16S rRNA基因突变。
- 106份生殖支原体阳性标本中,6份携带可能与四环素耐药相关的16S rRNA突变,患者无已知既往四环素治疗史。
临床怎么用
- 生殖支原体感染治疗中,若怀疑四环素耐药,可考虑检测16S rRNA突变。
- 体外诱导耐药试验结果不支持四环素短期使用即筛选出沙眼衣原体或生殖支原体耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tetracyclines are widely used for the treatment of bacterial sexually transmitted infections (STIs) and recently have been used successfully for post-exposure prophylaxis of STIs in MSM. We investigated the in vitro and in vivo development of tetracycline resistance in Chlamydia trachomatis and Mycoplasma genitalium and evaluated 16S rRNA mutations associated with acquired resistance in other bacteria. METHODS: In vitro selection of resistant mutants of reference strains of C. trachomatis and M. genitalium was undertaken by serial passage in medium containing subinhibitory concentrations of tetracycline or doxycycline, respectively. The 16S rRNA gene of the two microorganisms was amplified and sequenced at different passages, as were those of 43 C. trachomatis- and 106 M. genitalium-positive specimens collected in France from 2013 to 2019. RESULTS: No tetracycline- or doxycycline-resistant strains of C. trachomatis and M. genitalium, respectively, were obtained after 30 serial passages. The tetracycline and doxycycline MICs were unchanged and analysis of the 16S rRNA gene, the molecular target of tetracyclines, of C. trachomatis and M. genitalium revealed no mutation. No mutation in the 16S rRNA gene was detected in C. trachomatis-positive specimens. However, six M. genitalium-positive specimens harboured a mutation potentially associated with tetracycline resistance without known prior tetracycline treatment for patients. CONCLUSIONS: Tetracyclines did not select in vitro-resistant mutants of C. trachomatis or M. genitalium. However, 16S rRNA mutations either responsible for or associated with tetracycline resistance in other bacteria, including mycoplasma species, were identified in several M. genitalium-positive specimens.
引用
- Le Roy C, Touati A, Balcon C, et al. Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis. J Antimicrob Chemother. 2021. PMID: 33537731. doi:10.1093/jac/dkab016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。